Enlivex Therapeutics Ltd (ENLV)

Enlivex Therapeutics Ltd (ENLV) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4M; returns 1 day -13.0%, 1 week -15.4%, 1 year -98.9%.

Enlivex Therapeutics Ltd. is a clinical-stage Israeli biopharmaceutical company focused on developing and commercializing immunotherapies. Their lead product, Allocetra, is designed to reprogram macrophages to treat conditions involving unbalanced immune responses.

Groups ENLV belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Israel Companies
• Israel
• Biopharmaceutical
• Healthcare
• Immunotherapy
• Strategic Pivot
• Cryptocurrency Adjacent
• Blockchain Technology

ENLV financial model: income statement, cash flow and balance sheet